James Hamilton

Medicine & Life Sciences

1. Liver Transplantation 100%
2. Methylation 90%
3. Barrett Esophagus 84%
4. Hepatocellular Carcinoma 74%
5. Liver 61%
6. Adenocarcinoma 60%
7. Hepatolenticular Degeneration 56%
8. Epigenomics 47%
9. Coronavirus 42%
10. Esophageal Neoplasms 41%
11. Liver Diseases 41%
12. Genes 38%
13. Neoplasms 38%
14. Biomarkers 37%
15. Esophageal Squamous Cell Carcinoma 33%
16. Copper 31%
17. Antiviral Agents 30%
18. Liver Neoplasms 29%
19. Transplant Recipients 26%
20. Hepatocytes 26%
21. Liver X Receptors 26%
22. Tachykinins 25%
23. Stomach Neoplasms 25%
24. Copper Transport Proteins 24%
25. Tissue Donors 24%
26. MicroRNAs 24%
27. Hepatic Stellate Cells 23%
28. Fatty Liver 23%
29. End Stage Liver Disease 22%
30. Ouabain 21%
31. Nucleosides 20%
32. Liver Cirrhosis 20%
33. Mortality 20%
34. Esophagus 20%
35. Somatostatin 20%
36. Hepacivirus 19%
37. Fibrosis 19%
38. Therapeutics 18%
39. DNA 18%
40. Hepatitis B 18%
41. Colonic Neoplasms 18%
42. polo-like kinase 1 17%
43. Carcinogenesis 16%
44. Immunoglobulins 16%
45. Bilirubin 16%
46. Multicenter Studies 16%
47. bromopyruvate 16%
48. Budd-Chiari Syndrome 16%
49. Messenger RNA 16%
50. Activated-Leukocyte Cell Adhesion Molecule 16%